SPRINGWORKS THERAPEUTICS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2025-03-31 was $12.87M, a 98.08% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2024-12-31 was $523.00K, a 106.72% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2024-09-30 was $499.00K, a 89.02% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2024-06-30 was $919.00K, a 161.08% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2024 was $8.44M, a 201.36% increase from fiscal 2023.
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2023 was $2.80M, a 108.80% increase from fiscal 2022.
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2022 was $1.34M.
- SPRINGWORKS THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2021 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-03-31 | $12.87M 10-Q · filed 2025-05-09 | $14.81M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $8.44M 10-K · filed 2025-02-20 |
| 2024-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.17M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-06-30 | $919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $7.93M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-03-31 | $6.50M 10-Q · filed 2025-05-09 | $7.37M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.80M 10-K · filed 2025-02-20 |
| 2023-09-30 | $264.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.55M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.50M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.93M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.34M 10-K · filed 2025-02-20 |
| 2022-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |